Koussay Dellagi

Recombinant BCG expressing the leishmania surface antigen Gp63 induces protective immunity against Leishmania major infection in BALB/c mice.

S. Abdelhak, K. Dellagi, B. Gicquel, 1995, Microbiology.

A novel missense mutation in the gene encoding SLURP‐1 in patients with Mal de Meleda from northern Tunisia

S. Abdelhak, S. Boubaker, M. Mokni, 2003, The British journal of dermatology.

A randomized, placebo-controlled trial in Tunisia treating cutaneous leishmaniasis with paromomycin ointment.

P. Olliaro, K. Dellagi, A. Ben Salah, 1995, The American journal of tropical medicine and hygiene.

First-line thalidomide–dexamethasone therapy in preparation for autologous stem cell transplantation in young patients (<61 years) with symptomatic multiple myeloma

K. Dellagi, A. Saâd, T. Othman, 2005, Bone Marrow Transplantation.

Seroepidemiology of hepatitis B, C and delta viruses in Tunisia.

K. Dellagi, A. Ben Salah, H. Triki, 1997, Transactions of the Royal Society of Tropical Medicine and Hygiene.

Protein S deficiency and antibodies to protein S in patients with Behçet's disease.

K. Dellagi, S. Guermazi, M. Hamza, 1997, Thrombosis research.

Development of an ELISA for the detection of scorpion venoms in sera of humans envenomed by Androctonus australis garzonii (Aag) and Buthus occitanus tunetanus (Bot): correlation with clinical severity of envenoming in Tunisia.

K. Dellagi, M. El Ayeb, F. Abroug, 1998, Toxicon : official journal of the International Society on Toxinology.